TORONTO and CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with unique, core technology to predict novel targets on the molecular surface of complex proteins, announced today that, in addition to its ongoing program to develop a high-throughput and accurate test for detection of antibodies to the causative agent of COVID-19, it has expanded its collaboration with BC Neuroimmunology (BCNI) to include development of highly sensitive and specific assays to support accurate screening and diagnosis of Alzheimers disease (AD).
Both BCNI and ProMIS Neurosciences have years of experience utilizing surface plasmon resonance (SPR) technology, and believe that recent, significant advances in throughput and stability are likely to make SPR a broadly used and cost-effective diagnostic platform. SPR is expected to offer greater accuracy, flexibility and adaptability compared to ELISA (enzyme-linked immunosorbent assay), the prevailing standard.
The current COVID-19 pandemic has created a need for the rapid expansion of accurate serology testing for the presence of antibodies to the virus causing COVID-19. It is widely acknowledged that such a test for COVID-19 immunity is essential to understanding patterns of immunity in the community and supporting an effective surveillance program. As recently announced, the collaboration between ProMIS and BCNI is making significant progress towards the development of an SPR-based antibody assay, aiming to achieve 100% sensitivity and 99.9% specificity for the virus causing COVID-19.
The expanded collaboration between BCNI and ProMIS is designed to address the anticipated launches of disease-modifying treatments in the Alzheimers/dementia area, which will necessitate the broad availability of appropriate and accurate diagnostic assays. SPR will be used in this context to develop sensitive blood-based AD diagnostic tests quickly and cost-effectively.
Dr. Hans Frykman, Chief Executive Officer of BCNI and a globally recognized neuro-immunologist stated: We firmly believe that SPR will displace tests based on ELISA, a decades-old technology, due to its superior accuracy and flexibility. At BCNI, we are developing high-throughput SPR tests in conjunction with ProMIS whose unique peptide antigens are anticipated to be a critical component for development and commercialization of top-quality assays targeting infectious disease, such as COVID-19, and neurodegenerative disease, such as Alzheimers.
Commenting on the expanded collaboration with BCNI, Eugene Williams, ProMIS executive chairman, stated: It has been very clear to us since the launch of ProMIS that diagnostics represent an important application of our unique technology platform. We have announced significant progress on development of an SPR-based antibody test for COVID-19 and believe high quality assays in this space are necessary to help safely get the economy back on track. In the field of neuroscience, the anticipated launch of aducanumab and BAN2401 for treatment of Alzheimers disease will create a dramatic increase in demand for dementia screening and diagnostics. We intend to help address this very important unmet need by capitalizing on our existing portfolio of antibodies and antigens and applying these existing assets to BCNIs outstanding expertise in the development of high performance diagnostic tests.
About ProMIS Neurosciences
ProMIS Neurosciences, Inc. is a development stage biotechnology company whose unique core technology is the ability to rationally predict the site and shape (conformation) of novel targets known as Disease Specific Epitopes on the molecular surface of proteins. In the infectious disease setting, these disease-specific epitopes represent peptide antigens that can be used as an essential component to create accurate and sensitive serological assays to detect the presence of antibodies that arise in response to a specific infection, such as COVID-19. These peptide antigens can also be used to create potential therapeutic antibodies to treat active infection, as well as serve as the basis for development of vaccines. ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts. ProMIS is listed on the Toronto Stock Exchange under the symbol PMN, and on the OTCQB Venture Market under the symbol ARFXF.
Visit us at http://www.promisneurosciences.com or follow us onTwitter and LinkedIn. To learn more about COVID-19 antibody testing, listen at ProMIS Neurosciences website.
For media inquiries, please contact:Shanti Skiffingtonshanti.skiffington@gmail.comTel. 617 921-0808
For Investor Relations please contact:Alpine Equity AdvisorsNicholas Rigopulos, Presidentnick@alpineequityadv.comTel. 617 901-0785
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
- Elusive Cures: Why Neuroscience Hasnt Solved Brain Disordersand How We Can Change That, an excerpt - The Transmitter - June 10th, 2025 [June 10th, 2025]
- Nanowire Retinal Implant Restores Vision and Sees Infrared - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO... - June 10th, 2025 [June 10th, 2025]
- Obeying Orders Lowers Moral Responsibility Perception in the Brain - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Family Time and Parental Bonding Linked to Better Sleep in Preteens - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Study Links Gut Bacteria to MS Risk and Reveals Key Triggers - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant... - June 10th, 2025 [June 10th, 2025]
- Sleep-Wake Perception Intact in Many With Insomnia - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Cannabis Use Among U.S. Seniors Has Surged 46% in Just Two Years - Neuroscience News - June 10th, 2025 [June 10th, 2025]
- Anoki Integrates With Magnite While Seedtag Adds Neuroscience To Find Emotional Connections - TVREV - June 10th, 2025 [June 10th, 2025]
- Neuroscience: Knowing People's Names Makes You Empathize With Them Better. (By the Way, My Name Is Bill) - Inc.com - June 1st, 2025 [June 1st, 2025]
- Kindness Sparks Cooperation by Boosting Social Connectedness - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Neuroscience and Genetics of ADHD and Neurodevelopment - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- The Neuroscience of Cancer - Harvard Medicine Magazine - June 1st, 2025 [June 1st, 2025]
- Singing to Infants Boosts Mood and Bonding - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Neuroscience: Go Swimming and Your Brain Will Thank You - Inc.com - June 1st, 2025 [June 1st, 2025]
- Blood Fat Links Found Between Heart Risk and Alzheimers - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- Tiny Brain Cell Cluster Found to Drive Obesity and Overeating - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- New Neuroscience Shows Why Its So Important to Read Aloud to Your Kids - Inc.com - June 1st, 2025 [June 1st, 2025]
- Cats Can Recognize Their Owners by Smell Alone - Neuroscience News - June 1st, 2025 [June 1st, 2025]
- St. Lukes Center for Neuroscience Helps Those with Same Illness as Billy Joel - TAPinto - June 1st, 2025 [June 1st, 2025]
- These triplets who graduated from Georgia Tech with neuroscience degrees head to medical school - 11Alive.com - June 1st, 2025 [June 1st, 2025]
- Gabe Newell co-founded a neuroscience company in 2019 and its first brain chip is expected to ship later this year - PC Gamer - June 1st, 2025 [June 1st, 2025]
- Next-Gen Painkiller Blocks Pain Without the High - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Inflammation Triggers Repetitive Behaviors in ASD and OCD - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Astrocytes Take Center Stage in Brain Function and Behavior - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Setting the SCENE for Neuroscience Breakthroughs - Mellon College of Science - Carnegie Mellon University - May 21st, 2025 [May 21st, 2025]
- Long COVID Brain Fog Linked to Inflammation and Stress Markers - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Warren Buffett Says Youre Too Focused on the Negative. Heres the Neuroscience Showing Hes Right - Inc.com - May 21st, 2025 [May 21st, 2025]
- Reading Fiction Boosts Empathy and Fights Loneliness - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Astrocytes, Not Neurons, Drive Brains Attention and Alertness - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Mapping Young Minds: The Neuroscience Behind Babilou Family Singapore's Revolutionary Education Model - PR Newswire - May 21st, 2025 [May 21st, 2025]
- Loneliness Linked to 24% Higher Risk of Hearing Loss - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Eureka Moments Double Memory by Rewiring the Brain - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- Scientists use brain activity to predict StarCraft II skill in fascinating new neuroscience research - psypost.org - May 21st, 2025 [May 21st, 2025]
- Stress of Long Work Hours May Physically Alter the Brain - Neuroscience News - May 21st, 2025 [May 21st, 2025]
- The Neuroscience of Dopamine: How to Triumph Over Constant Wanting - Next Big Idea Club - May 12th, 2025 [May 12th, 2025]
- Verbal Abuse in Childhood Rewires the Developing Brain - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Heavy Social Media Use Linked to Believing and Spreading Fake News - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Brain Cells That Predict What Comes Next, Even When Its New - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- The Temperature | Better happiness through neuroscience - The Colorado Sun - May 12th, 2025 [May 12th, 2025]
- Genes Strongly Influence When Babies Take Their First Steps - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Using Music to Detect Concussion in Kids - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Boosting Klotho Protein Slows Aging and Enhances Health - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Eye Movements Set the Speed Limit for What You Can See - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Seeing Is Believing: How We Judge AI as Creative or Not - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Exercise Boosts Stem Cell Therapy for Parkinsons - Neuroscience News - May 12th, 2025 [May 12th, 2025]
- Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease - BioSpace - May 12th, 2025 [May 12th, 2025]
- Sheffield Lab: Understanding the neuroscience of memories - University of Chicago News - April 27th, 2025 [April 27th, 2025]
- Prenatal Stress Leaves Lasting Molecular Imprints on Babies - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Dean Buonomano explores the concept of time in neuroscience and physics - The Transmitter - April 27th, 2025 [April 27th, 2025]
- Psychedelics May Reset Brain-Immune Link Driving Fear and Anxiety - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Infant Social Skills Thrive Despite Hardship - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- From Cologne to Country Roads: One scientist's interdisciplinary journey to build bridges (and robotic insects) between neuroscience and engineering -... - April 27th, 2025 [April 27th, 2025]
- Eyes Reveal Intentions Faster Than We Think - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Immune Resilience Identified as Key to Healthy Aging and Longevity - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Energy Starvation Triggers Dangerous Glutamate Surges in the Brain - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- WVU Rockefeller Neuroscience Institute first in U.S. to successfully test innovative brain-computer interface technology to decode speech and language... - April 27th, 2025 [April 27th, 2025]
- Microglia Reprogrammed to Deliver Precision Alzheimers Therapies - Neuroscience News - April 27th, 2025 [April 27th, 2025]
- Neuroscience Says Music Is an Emotion Regulation Machine. Heres What to Play for Happiness, Productivity, or Deep Thinking - Inc.com - April 19th, 2025 [April 19th, 2025]
- Early Maternal Affection Shapes Key Personality Traits for Life - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- Elons new neuroscience major highlighted by Greensboro News & Record - Elon University - April 19th, 2025 [April 19th, 2025]
- Brain Blast event at St. Lawrence University teaches local students neuroscience - North Country Now - April 19th, 2025 [April 19th, 2025]
- AI Reveals What Keeps People Committed to Exercise - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- The "Holy Grail" of Neuroscience? Researchers Create Stunningly Accurate Digital Twin of the Brain - The Debrief - April 19th, 2025 [April 19th, 2025]
- Annenberg School Vice Dean Emily Falk publishes book on the neuroscience of decision-making - The Daily Pennsylvanian - April 19th, 2025 [April 19th, 2025]
- Music-Induced Chills Trigger Natural Opioids in the Brain - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- What We Value: The Neuroscience of Choice and Change - think.kera.org - April 19th, 2025 [April 19th, 2025]
- Kile takes top neuroscience post at Sutter Health as system pushes to align care, expand trials - The Business Journals - April 19th, 2025 [April 19th, 2025]
- A Grain of Brain, 523 Million Synapses, and the Most Complicated Neuroscience Experiment Ever Attempted - SciTechDaily - April 19th, 2025 [April 19th, 2025]
- Mild Brain Stimulation Alters Decision-Making Speed and Flexibility - Neuroscience News - April 19th, 2025 [April 19th, 2025]
- Cannabis studies were informing fundamental neuroscience in the 1970s - Nature - April 10th, 2025 [April 10th, 2025]
- To make a meaningful contribution to neuroscience, fMRI must break out of its silo - The Transmitter - April 10th, 2025 [April 10th, 2025]
- Steve Jobss Unexpected Secret to Being More Creative (Backed by Neuroscience) - Inc.com - April 10th, 2025 [April 10th, 2025]
- Challenging Decades of Neuroscience: Brain Cells Are More Plastic Than Previously Thought - SciTechDaily - April 10th, 2025 [April 10th, 2025]
- Q&A: Lundbecks head of R&D on letting biology speak in neuroscience - Endpoints News - April 10th, 2025 [April 10th, 2025]
- Why it's hard to study the neuroscience of psychedelics : Short Wave - NPR - April 10th, 2025 [April 10th, 2025]
- Fear Sync: How Males and Females Respond to Stress Together - Neuroscience News - April 10th, 2025 [April 10th, 2025]
- Chemotherapy Disrupts Brain Connectivity - Neuroscience News - April 10th, 2025 [April 10th, 2025]
- Newly awarded NIH grants for neuroscience lag 77 percent behind previous nine-year average - The Transmitter - April 10th, 2025 [April 10th, 2025]